BioNJ Welcomes Randi Bromberg as Vice President, Communications and Marketing

TRENTON, NJ (November 13, 2015) — BioNJ, the trade association for New Jersey’s life sciences industry, announced that Randi Bromberg joined the organization as Vice President, Communications and Marketing. Randi brings more than 25 years of experience, including managing media relations and writing and executing forward-thinking marketing strategies and initiatives that foster member engagement, build… Read the full article

NJ Governor Christie Approves Biosimilars Legislation

New Jersey Governor Christie Approves Biosimilars Legislation — Making Biological Drug Alternatives More Widely Available TRENTON, NJ (November 10, 2015) – New Jersey Governor Chris Christie approved biosimilars legislation today, ensuring patient safety as they access this new category of FDA-approved biologic medicines. “We applaud the Governor for supporting this legislation,” said Debbie Hart, President… Read the full article

BioNJ’s Inaugural Inspiring Women in STEM Conference

BioNJ’s Inaugural Inspiring Women in STEM Conference A Day of Inspiration, Learning and Professional Growth Trenton, NJ (October 21, 2015) – BioNJ’s inaugural Inspiring Women in STEM Conference, scheduled for Friday, December 4 at Sanofi, Bridgewater, NJ, will bring together professionals of all levels from the STEM community for an empowering professional development program. Through forward-thinking presentations,… Read the full article

New Jersey’s Hart and Celgene and Johnson & Johnson Executives Named to Scientific American Worldview 100 Most Influential People in Biotechnology

Trenton, NJ (June 18, 2015) – BioNJ President and CEO Debbie Hart, along with five other New Jersey executives, including Bob Hugin, Chairman and CEO, Celgene; Sol Barer, Ph.D., Founder, Celgene, and Managing Partner, SJ Barer Consulting; Robert Hariri, M.D., Ph.D., Chairman and Founder, Celgene Cellular Therapeutics; Paul Stoffels, M.D., CSO, Johnson & Johnson; and Shirley… Read the full article

New Jersey State Assemblywoman Lampitt Honored as BIO State Legislator of the Year

Philadelphia, PA. (June 17, 2015) – The Biotechnology Industry Organization (BIO) announced today its selection of New Jersey State Assemblywoman Pamela Lampitt (6th District) as a state Legislator of the Year for 2015. Assemblywoman Lampitt is the prime sponsor of A-2477, which authorizes the prescription and dispensing of biosimilar products in New Jersey. Assemblywoman Lampitt… Read the full article

BioNJ and Pennsylvania Bio Form International Partnership with Taiwan Bio Industry Organization

Agreement signed at the Biotechnology Industry Organization (BIO) International Convention TRENTON, NJ– BioNJ, New Jersey’s statewide trade association representing research-based life sciences companies and stakeholders, and Pennsylvania Bio, the statewide trade association representing Pennsylvania’s life sciences industry, announced today a memorandum of understanding (MOU) with Taiwan Bio Industry Organization, the largest biotechnology organization in Taiwan…. Read the full article

New Jersey Showcases Life Science Leaders and Innovations at World’s Largest Biotechnology Event

  TRENTON, NJ — New Jersey will showcase its business strengths in the life science industry to a global audience next week at the world’s largest biotechnology conference, BIO International, being held at the Philadelphia Convention Center on June 15-18. More than 15,000 attendees are expected to attend this year’s BIO International Convention, which regularly… Read the full article

Unanimous Approval of A2477 – Making Biological Drug Alternatives More Widely Available

TRENTON, NJ (May 14, 2015) — BioNJ, The Gateway to Health, is pleased with the passage of A2477, legislation that will allow greater Patient access to more affordable FDA-approved biologic medicines. Biological medicines are vital to the treatment of conditions such as cancer, diabetes, infectious diseases and a variety of immune disorders. BioNJ’s rallying cry… Read the full article

Assembly Committee Releases Bill A2477

Trenton, NJ – Proposed legislation that will allow greater patient access to more affordable FDA-approved biologic medicines was passed unanimously by the New Jersey Assembly Health and Human Services Committee today. The bill, A2477, also includes provisions for physician notification when a biosimilar bill is substituted for a biologic drug. “Biological medicines are vital to… Read the full article